Aussie Researchers push ahead on MDMA study as UK starts LSD experiments


As UK researchers begin human therapeutic experiments using the psychedelic drug LSD an Australian group are setting up the nation’s first clinical study using MDMA to treat post-traumatic stress disorder (PTSD).

Steve McDonald, from Australian organisation, Psychedelic Research in Science and Medicine (PRISM), told ninemsn that getting such a study up in Australia had been very difficult, even though it is legal.

“We’re finding that the medical profession in Australia is very conservative, and people are reluctant to get involved in anything concerning an illicit drug, even though it’s legal research. People are very concerned about public image,” he said.

Read more here:

Share this post

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.


We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.


Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search